Anika Therapeutics, Inc. ANIK

Company Overview

Anika Therapeutics, Inc. is a U.S.-based orthopedic-focused biotechnology company that develops, manufactures, and commercializes products intended to support bone preservation, joint health, and soft tissue repair. The company operates primarily within the orthopedics, sports medicine, and regenerative medicine industries, with a core scientific focus on hyaluronic acid (HA)–based technologies. Its products are used by orthopedic surgeons, sports medicine specialists, and other healthcare professionals to treat joint pain, cartilage damage, and musculoskeletal injuries.

Anika’s primary revenue drivers include injectable viscosupplementation products for osteoarthritis pain management and a growing portfolio of orthopedic implants and biologic solutions. The company has historically been recognized for its leadership in HA science, which has provided a defensible competitive position through proprietary manufacturing capabilities and regulatory expertise. Founded in 1992 and headquartered in Bedford, Massachusetts, Anika evolved from an HA-focused biomaterials company into a broader orthopedic solutions provider, particularly following a strategic pivot in the late 2010s toward sports medicine and joint preservation technologies.